TY - JOUR
T1 - Differences in outcomes between cesarean section in the second versus the first stages of labor
AU - Vitner, Dana
AU - Bleicher, Inna
AU - Levy, Eyal
AU - Sloma, Ronen
AU - Kadour-Peero, Einav
AU - Bart, Yossi
AU - Sagi, Shlomi
AU - Aviram, Amir
AU - Gonen, Ron
N1 - Publisher Copyright:
© 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2019/8/3
Y1 - 2019/8/3
N2 - Objective: We aimed to compare maternal morbidity and mortality of cesarean sections (CS) in the second versus first stage of labor. Study design: Retrospective study of all CS at a single, university-affiliated medical center, between January 2010 and December 2014. Eligibility was limited to term, singleton pregnancies with cephalic presentation. Maternal outcomes of second-stage CS were compared to those of first-stage CS. The primary outcome was defined as estimated blood loss >1000 ml. Results: Overall, 1004 women met the inclusion criteria, of which 290 (29%) had a second-stage CS and 714 (71%) had a first-stage CS. Women in the second-stage CS group had a higher nulliparity and hypertensive disorders rates and a lower rate of previous CS. Second-stage CS was associated with more than double the rate of estimated blood loss >1000 ml (9.7% versus 3.8%, p<.001), and more prone to unintentional uterine incision extension, uterine atony, hemoglobin decrease >2 g/l and antibiotic treatment for suspected endometritis. In a multivariable logistic regression model, second-stage CS was found to be independently associated with unintentional uterine incision extension (OR 6.8, 95% CI 4.1–11.2), uterine atony (OR 3.3, 95% CI 1.4–8.0) and antibiotic treatment for suspected endometritis (OR 2.6, 95% CI 1.4–5.1), but not with excessive blood loss (OR 1.5, 95% CI 0.8–2.8). Additionally, failed assisted vaginal delivery prior to second-stage CS was not associated with a higher rate of complications. Conclusion: Second-stage CS is associated with higher rates of adverse maternal outcomes, mainly unintentional uterine incision extension, uterine atony, and suspected endometritis.
AB - Objective: We aimed to compare maternal morbidity and mortality of cesarean sections (CS) in the second versus first stage of labor. Study design: Retrospective study of all CS at a single, university-affiliated medical center, between January 2010 and December 2014. Eligibility was limited to term, singleton pregnancies with cephalic presentation. Maternal outcomes of second-stage CS were compared to those of first-stage CS. The primary outcome was defined as estimated blood loss >1000 ml. Results: Overall, 1004 women met the inclusion criteria, of which 290 (29%) had a second-stage CS and 714 (71%) had a first-stage CS. Women in the second-stage CS group had a higher nulliparity and hypertensive disorders rates and a lower rate of previous CS. Second-stage CS was associated with more than double the rate of estimated blood loss >1000 ml (9.7% versus 3.8%, p<.001), and more prone to unintentional uterine incision extension, uterine atony, hemoglobin decrease >2 g/l and antibiotic treatment for suspected endometritis. In a multivariable logistic regression model, second-stage CS was found to be independently associated with unintentional uterine incision extension (OR 6.8, 95% CI 4.1–11.2), uterine atony (OR 3.3, 95% CI 1.4–8.0) and antibiotic treatment for suspected endometritis (OR 2.6, 95% CI 1.4–5.1), but not with excessive blood loss (OR 1.5, 95% CI 0.8–2.8). Additionally, failed assisted vaginal delivery prior to second-stage CS was not associated with a higher rate of complications. Conclusion: Second-stage CS is associated with higher rates of adverse maternal outcomes, mainly unintentional uterine incision extension, uterine atony, and suspected endometritis.
KW - adverse maternal outcomes
KW - Cesarean section
KW - second stage of labor
KW - second-stage CS
UR - http://www.scopus.com/inward/record.url?scp=85042405781&partnerID=8YFLogxK
U2 - 10.1080/14767058.2018.1440545
DO - 10.1080/14767058.2018.1440545
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 29471705
AN - SCOPUS:85042405781
VL - 32
SP - 2539
EP - 2542
JO - Journal of Maternal-Fetal and Neonatal Medicine
JF - Journal of Maternal-Fetal and Neonatal Medicine
SN - 1476-7058
IS - 15
ER -